Targeting hormonal therapy for endometrial cancer is opening up the potential to improve outcomes without overtreating in the molecular era. A dramatic increase in endometrial cancer cases and stark ...

HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...

A combination of the poly-ADP ribose polymerase (PARP) inhibitor olaparib and the chemotherapy temozolomide shows preliminary activity in advanced uterine leiomyosarcoma that has progressed on ...

Experts debate MMR/p53 testing, liquid biopsy, and immunotherapy sequencing in endometrial cancer, refining prognosis and relapse treatment.

Please provide your email address to receive an email when new articles are posted on . Relugolix combination therapy resulted in reduced heavy menstrual bleeding for 82.9% of Black women with uterine ...

By Dr. Sanchari Sinha Dutta, Ph.D. A landmark randomized trial shows that preparing the uterus using natural ovulation ...

Please provide your email address to receive an email when new articles are posted on . More women in the relugolix group maintained menstrual blood loss volume less than 80 mL vs. placebo. More women ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

After receiving radiation therapy for uterine cancer, you may experience fertility challenges, vaginal dryness, and bowel or bladder problems. Options to manage and relieve your side effects can vary.

Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...